Nervous System News and Research

Latest Nervous System News and Research

Harnessing the brain's immune system to combat Alzheimer's disease

A new study appearing in the Journal of Neuroinflammation suggests that the brain's immune system could potentially be harnessed to help clear the amyloid plaques that are a hallmark of Alzheimer's disease.

5 Nov 2015

Researchers successfully repair nerve cell damage in Alzheimer's dementia

In laboratory experiments on the basic mechanisms that cause Alzheimer's dementia, an international research team led by Heidelberg neurobiologist Prof. Dr. Ulrike Müller and a team of French scientists have succeeded in largely "repairing" the nerve cell damage typical in this disease.

5 Nov 2015

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

When it comes to fending off disease and helping prevent people from falling ill, the body's immune system -- armed with T-cells that help eliminate cancer cells, virus-infected cells and more -- is second to none. But exactly how the immune system works remains, in many ways, a mystery, as there are numerous cell types whose functions and interactions with our immune systems have not been well understood.

5 Nov 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

Scientists propose that Alzheimer's disease should be treated separately

Deciphering the mechanism that underlies the development of Alzheimer's disease in certain families but not in others, researchers at the Hebrew University of Jerusalem's Faculty of Medicine have proposed that the malady is actually a collection of diseases that probably should be treated with a variety of different approaches.

4 Nov 2015

Scientists identify protein that helps map brain tumours

Scientists have discovered a protein that helps map the edge of brain tumours more clearly so they show up on magnetic resonance imaging (MRI) scans, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool today.

3 Nov 2015

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

3 Nov 2015

United Cannabis files utility and PCT patent applications related to unique specifications of cannabinoids

United Cannabis Corporation today announced that it moved its provisional patent application to the next phase by filing a utility patent application related to the unique combinations of pharmaceutically active cannabinoids used to treat disorders of the nervous system, immune system and cancer with the U.S. Patent and Trademark Office.

3 Nov 2015

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Analysis of tumor RNA carried in platelets - blood components best known for their role in clotting - may prove to be more useful than other "liquid biopsy" technologies for diagnosing cancer and determining its primary location and potential therapeutic approaches.

31 Oct 2015

Stem cell transplantation may offer viable treatment for Alzheimer's disease patients

Alzheimer's disease (AD), affecting millions worldwide, is the leading cause of dementia. The prevalence of AD is rapidly increasing, and will possibly affect over 100 million people by 2050, yet there are no effective therapies for the disease.

31 Oct 2015

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S. rights for ADASUVE (loxapine) inhalation powder from Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., with an estimated target completion date of January 1, 2016.

31 Oct 2015

Very long-term outcomes of childhood onset epilepsy reported

A study in Epilepsia presents seizure remission outcomes as well as detailed clinical and neurological findings from a minimum 45-year follow-up of a Finnish cohort of individuals with childhood-onset epilepsy.

30 Oct 2015

Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.

30 Oct 2015

Single gene variation may influence obesity in children, adults

A single variation in the gene for brain-derived neurotropic factor (BDNF) may influence obesity in children and adults, according to a new study funded by the National Institutes of Health.

30 Oct 2015

New magnetic field delivery method could help treat traumatic brain injury

Treating traumatic brain injury (TBI) using stem cell therapy is an important area of current research. However, injecting stem cells into the central nervous system has serious drawbacks, including intracranial hemorrhage and cells failing to reach TBI-affected areas of the brain.

30 Oct 2015

Adelaide researchers identify key protein involved in 'super-inflammatory' immune response

Researchers have made another important step in the progress towards being able to block the development of multiple sclerosis (MS) and other autoimmune diseases.

29 Oct 2015

Older women who complain of memory problems may experience thinking impairment decades later

New research suggests that older women who complain of memory problems may be at higher risk for experiencing diagnosed memory and thinking impairment decades later. The study is published in the October 28, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Oct 2015

GDF10 molecule identified as a key player in repair mechanisms after stroke

Looking at brain tissue from mice, monkeys and humans, scientists have found that a molecule known as growth and differentiation factor 10 (GDF10) is a key player in repair mechanisms following stroke. The findings suggest that GDF10 may be a potential therapy for recovery after stroke.

29 Oct 2015

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.

29 Oct 2015

Endocannabinoids can affect development of baby's pancreas

According to the latest research results from the Medical University of Vienna, endocannabinoids, cannabis-like substances produced by the body itself, can affect the development of a baby's pancreas. The study also highlights the importance of diet during pregnancy for the foetal pancreas to form.

23 Oct 2015

Nervous System News and Research

Latest Nervous System News and Research

Harnessing the brain's immune system to combat Alzheimer's disease

Researchers successfully repair nerve cell damage in Alzheimer's dementia

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Scientists propose that Alzheimer's disease should be treated separately

Scientists identify protein that helps map brain tumours

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

United Cannabis files utility and PCT patent applications related to unique specifications of cannabinoids

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Stem cell transplantation may offer viable treatment for Alzheimer's disease patients

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Very long-term outcomes of childhood onset epilepsy reported

Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Single gene variation may influence obesity in children, adults

New magnetic field delivery method could help treat traumatic brain injury

Adelaide researchers identify key protein involved in 'super-inflammatory' immune response

Older women who complain of memory problems may experience thinking impairment decades later

GDF10 molecule identified as a key player in repair mechanisms after stroke

Yervoy approved for patients at high risk of developing recurrence of melanoma after surgery

Endocannabinoids can affect development of baby's pancreas

Everything you need to know about epilepsy eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Nervous System News and Research

Latest Nervous System News and Research

Everything you need to know about epilepsy eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in